Leukemia, Myelomonocytic, Acute - 25 Studies Found
Active, not recruiting |
: Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2010-12-01 : Drug: Decitabine Decitabine will be administered at a dose of 20 mg/m2 infused over a 1 hour period once |
Completed |
: Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia : Leukemia : 2010-11-04 :
|
Completed |
: Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML) : Chronic Myelomonocytic Leukemia : 2010-04-01 : Drug: Decitabine 20mg/m2/day, one hour intravenous infusion, every day during 5 days |
Recruiting |
: The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2009-11-06 |
Recruiting |
: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia :
: |
Terminated |
: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Completed |
: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia :
|
Active, not recruiting |
: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy :
|
Completed |
: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma :
|
Completed |
: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia :
|